Alcon, Inc. Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	70
ISBN Number	not applicable
Product Code	GMD04714

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Alcon, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
3 Business Description
- 3.1 Business Overview
- 3.2 Alcon International
  - 3.2.1 Overview
  - 3.2.2 Financials
  - 3.2.3 Market View
- 3.3 Alcon United States
  - 3.3.1 Overview
  - 3.3.2 Financials
  - 3.3.3 Market View
- 3.4 Major Products and Services
  - 3.4.1 Overview
4 History
5 Business Strategy
- 5.1 Mission Statement
- 5.2 Strategy
- 5.3 Corporate Social Responsibility
  - 5.3.1 Overview
  - 5.3.2 Specific CSR Initiatives
6 Value Chain Analysis
- 6.1 Manufacturing
  - 6.1.1 In House Manufacturing
  - 6.1.2 Outsourcing
- 6.2 Product Development
  - 6.2.1 Regulatory Approvals
  - 6.2.2 Clinical Trials
  - 6.2.3 Research and Development
- 6.3 Sales and Marketing
  - 6.3.1 Partnerships and Alliances
  - 6.3.2 Licensing Agreements
7 Competitors
8 Share Holding Structure
9 Key Employees
10 Key Employee Biographies
11 Company Statement
12 Locations And Subsidiaries
- 12.1 Head Office
- 12.2 Other Locations & Subsidiaries
13 Recent Developments
- 13.1 Strategy And Business Planning
  - 13.1.1 Apr 13, 2008: Alcon To Build New Pharmaceutical Manufacturing Plant In Singapore
  - 13.1.2 Sep 10, 2007: Alcon To Expand Swiss Operations
- 13.2 Financial Announcements
  - 13.2.1 Jul 23, 2008: Alcon Reports 2Q 2008 Results
  - 13.2.2 Jun 20, 2008: Alcon Laboratories Spends $0.24 Million On Lobbying In Q1 2008
  - 13.2.3 Jun 17, 2008: Alcon To Declare Q2 2008 Results
  - 13.2.4 May 06, 2008: Alcon Approves Dividend
  - 13.2.5 Apr 23, 2008: Alcon Declares Q1 2008 Results
  - 13.2.6 Mar 28, 2008: Alcon To Declare Q1 2008 Results
  - 13.2.7 Feb 06, 2008: Alcon Declares Q4 2007 Results
  - 13.2.8 Oct 24, 2007: Alcon Declares Q3 2007 Results
  - 13.2.9 Jul 25, 2007: Alcon Declares Q2 2007 Results
  - 13.2.10 May 09, 2007: Alcon Approves Dividend
  - 13.2.11 Apr 25, 2007: Alcon's Q1 Global Sales Up By 14.3%
  - 13.2.12 Mar 26, 2007: Alcon Announces Q1 2007 Financial Release Date
  - 13.2.13 Feb 07, 2007: Alcon Declares Q4 2006 Results
  - 13.2.14 Oct 23, 2006: Alcon's Q3 Global Sales Up By 12.4%
  - 13.2.15 Sep 18, 2006: Alcon Announces Q3 2006 Financial Release Date
  - 13.2.16 Sep 08, 2006: Alcon Approves Repurchase Of 5 Million Additional Shares
  - 13.2.17 Jul 24, 2006: Alcon's Q2 Global Sales Up 11.8% To $1,310.8 Million
  - 13.2.18 Jun 19, 2006: Alcon Announces Q2 2006 Financial Release Date
  - 13.2.19 May 02, 2006: Alcon Approves Dividend
- 13.3 Corporate Communications
  - 13.3.1 May 06, 2008: Alcon Announces Board Changes
  - 13.3.2 Mar 10, 2008: Alcon Announces Management Changes
  - 13.3.3 Sep 10, 2007: Alcon Senior Vice President To Retire
  - 13.3.4 Jul 16, 2007: Alcon Appoints New CFO
  - 13.3.5 Jun 26, 2007: Alcon CFO To Leave
  - 13.3.6 May 09, 2007: Alcon Elects Board Members
  - 13.3.7 May 02, 2006: Alcon Elects Board Members
- 13.4 Legal and Regulatory
  - 13.4.1 Jun 26, 2007: Bausch & Lomb Files Suit Against Alcon
  - 13.4.2 Jul 10, 2006: AMO Announces Patent Infringement Settlement With Alcon
- 13.5 Government and Public Interest
  - 13.5.1 Jun 10, 2008: FDA Panel Recommends Stricter Contact Lens Labeling
- 13.6 Product News
  - 13.6.1 Jun 25, 2008: Alcon Enters Into Patent Cross-Licensing Agreement With AMO
  - 13.6.2 Feb 01, 2007: Alcon's AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens approved by FDA
  - 13.6.3 Feb 01, 2007: Alcon's AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens Approved By FDA
  - 13.6.4 Dec 18, 2006: Alcon Recalls 'Systane Free' Eye Drops
  - 13.6.5 Dec 15, 2006: (ACL) Announces Voluntary Recall Of Systane(R) Free LIQUID GEL Lubricant Eye Drops In The United States, Including Puerto Rico
  - 13.6.6 Oct 25, 2006: Childrens Hospital of Austin is Helping Save Young Patients Eyesight with New Technology
  - 13.6.7 Jun 02, 2006: Alcon gets U.S. FDA approval for Ladar6000 Excimer Laser, Wavefront-Guided Hyperopia
  - 13.6.8 May 21, 2006: AcrySof IQ IOL Designated as a New Technology Intraocular Lens
  - 13.6.9 Oct 12, 2005: FDA Approves Alcon's OPTI-FREE RepleniSH MPDS
  - 13.6.10 Jan 15, 2005: Combination system provides extra protection
  - 13.6.11 Mar 01, 2004: Surgeons laud various advantages of viscoelastic duo
  - 13.6.12 Apr 14, 2003: Alcon Introduces INFINITI Vision System, a Revolutionary Cataract Removal System
  - 13.6.13 Feb 28, 2003: What's Coming in 2003
  - 13.6.14 Oct 24, 2002: Alcon Reports Third Quarter Operating Results
- 13.7 Product Approvals
  - 13.7.1 Feb 01, 2007: Alcon's AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens approved by FDA
  - 13.7.2 Feb 01, 2007: Alcon's AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens Approved By FDA
  - 13.7.3 Oct 12, 2005: FDA Approves Alcon's OPTI-FREE RepleniSH MPDS
14 Alcon, Inc. Pipeline Products
- 14.1 Alcon, Inc. Product Pipeline Analysis
  - 14.1.1 Alcon, Inc. Pipeline Products By Equipment Type
  - 14.1.2 Alcon, Inc. Pipeline Products By Development Stage
  - 14.1.3 Alcon, Inc. Pipeline Products By Therapy Area
  - 14.1.4 Alcon, Inc. Pipeline Products By Clinical Trials
- 14.2 AcrySof ReSTOR IOL +3.0 Add
  - 14.2.1 Product Description
  - 14.2.2 Product Status
- 14.3 AcrySof Low Power ReSTOR lens
  - 14.3.1 Product Description
  - 14.3.2 Product Status
- 14.4 AcrySof thin-profile IOL
  - 14.4.1 Product Description
  - 14.4.2 Product Status
- 14.5 AcrySof ReSTOR Toric IOL
  - 14.5.1 Product Description
  - 14.5.2 Product Status
- 14.6 AcrySof Angle-supported Phakic Lens
  - 14.6.1 Product Description
  - 14.6.2 Product Status
  - 14.6.3 Clinical Trials
- 14.7 New CONSTELLATION Vitreoretinal System
  - 14.7.1 Product Description
  - 14.7.2 Product Status
15 Appendix
- 15.1 Methodology
  - 15.1.1 Coverage
  - 15.1.2 Secondary Research
  - 15.1.3 Primary Research
  - 15.1.4 Expert Panel Validation
- 15.2 Contact Us
- 15.3 About Global Markets Direct
- 15.4 Disclaimer
1 List of Tables
- Table 1: Alcon, Inc.,Key Facts, 2007
- Table 2: Alcon, Inc., Share Holding Structure
- Table 3: Alcon, Inc., Key Employees, 2007
- Table 4: Alcon, Inc., Other Locations
- Table 5: Alcon, Inc. Pipeline Products by Equipment Type
- Table 6: Alcon, Inc. Pipeline Products By Development Stage
- Table 7: Alcon, Inc. Pipeline Products By Therapy Area
- Table 8: Alcon, Inc. Pipeline Products By Clinical Trials
- 1.2 List of Figures
- Figure 1: Alcon, Inc., Value Chain Analysis
- Figure 2: Alcon, Inc. Pipeline Products By Development Stage
- Figure 3: Global Markets Direct Methodology